logo

Biotechnology News

Novartis AG (NVS) said that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency or EMA adopted a positive opinion for Farydak (panobinostat, previously known as LBH589) capsules, in combination with bortezomib and dexamethasone, for the treatment of adult patients...
Global biotechnology firm Biogen, Inc. (BIIB) and healthcare firm Swedish Orphan Biovitrum AB (SWTUY) announced that the European Medicines Agency (EMA) has accepted the Marketing Authorization Application (MAA) of ALPROLIX (rFIXFc). This validation signifies the initiation of the EMA's review process. The...
CTD Holdings, Inc. (CTDH.OB), a family of biotechnology growth companies that develop cyclodextrin-based treatments, announced that it has signed an agreement with UCSF Benioff Children's Hospital Oakland to transfer sponsorship of their US FDA Orphan Drug Designation for Trappsol Cyclo to CTD Holdings. CTD's...
More
Pharma-062515.jpg Aquinox Pharmaceuticals Inc.'s (AQXP) phase II clinical trial investigating the ability of 200mg oral, once daily AQX-1125 to reduce pain in female patients with bladder pain syndrome/interstitial cystitis, or BPS/IC, has not met the statistical endpoint.
Pharma-062315.jpg Alcobra Ltd.(ADHD) is scheduled to present results from its phase II clinical trial of MDX in adolescents and adults with Fragile X Syndrome on Wednesday, June 24, 2015 at 8:00am Eastern Time.
Transition-Therapeutics-Inc-TTHI-062215.jpg Shares of Transition Therapeutics Inc. (TTHI) (TTH.TO) have gained nearly 25% in the last one month, as the company awaits phase II study results of its neuropsychiatric drug candidate - ELND005.
More

Recall-Nice-061215.jpg

Walgreen Co. of Deerfield, Illinois is recalling Nice! Powdered Sugar Mini Donuts after consumer complaints alleging that mold was observed on some products.

Recall-Green-Raisins-Sunderkhani-060515.jpg

Best Cash & Carry is voluntarily recalling its BEST BRAND GREEN RAISIN (Sunderkhani) as the product may contain undeclared sulfites. Packed in an un-coded, 7 oz. plastic bag, the recalled product was sold in New York, Connecticut and New Jersey.

NatiralGrocers-Recall-052815.jpg

Vitamin Cottage Natural Food Markets Inc., commonly refered to as "Natural Grocers", is recalling two lots of Natural Grocers brand Macadamia nuts as the product has the potential to be contaminated with the harmful Salmonella bacteria.

Bean-Sprouts-051215.jpg

Good Seed Inc. of Springfield, Virginia is recalling all packages of soybean sprouts and mung bean sprouts due to potential contamination with the deadly bacterium Listeria monocytogenes.

More
Date Company Name Ticker Drug Event Outcome Details
09/08/2015 Synageva BioPharma Corp. GEVA Kanuma (BLA) FDA decision on Kanuma for the treatment of lysosomal acid lipase deficiency
09/05/2015 TESARO, Inc. TSRO Oral Rolapitant (NDA) FDA decision on oral Rolapitant for the prevention of chemotherapy-induced nausea and vomiting
09/05/2015 TESARO, Inc. TSRO Oral Rolapitant (NDA) FDA decision on Oral Rolapitant for prevention of chemotherapy-induced nausea and vomiting (C
08/27/2015 Amgen Inc. AMGN Evolocumab (BLA) FDA decision on Evolocumab for the treatment of high cholesterol
08/27/2015 Bristol-Myers Squibb Co. BMY Opdivo (sBLA) FDA decision on Opdivo for expanded use in treating previously untreated patients with unresectable or metastatic melanoma.
More
Results Date Company Name Ticker Event Indication Outcome
Mid 2015 Vical Inc. VICL Efficacy data from phase 1/2 trial of Vaxfectin(R)-formulated therapeutic vaccine Herpes simplex virus type 2 (HSV-2)
Mid 2015 Fate Therapeutics, Inc FATE Full data on primary efficacy endpoint from phase II study of PROHEMA Hematologic malignancies
Mid 2015 Celldex Therapeutics Inc. CLDX First interim analysis of phase III 3 Study of Rindopepimut Frontline Glioblastoma
Mid 2015 Fate Therapeutics, Inc FATE Full data on primary efficacy endpoint from phase II study of PROHEMA Hematologic malignancies in adult subjects undergoing double umbilical cord blood transplantation
Mid 2015 Trevena, Inc. TRVN Data from Phase 2b Study of TRV130 Acute Postoperative Pain
More
Alder BioPharmaceuticals Inc. (ALDR) has offered to sell 4.49 million shares of its common stock to the public at a price of $44.50 each. The underwrites have a 30-day option to purchase up to 674,157 additional shares of common stock at the public offering price.
bluebird bio Inc. (BLUE) has offered to sell 2.94 million shares of its common stock to the public at a price of $170.00 each. The underwriters have a 30-day option to purchase an additional 441,176 shares of common stock.
More
Researchers of a new study have found that children with good verbal working memories are better at lying. The study, published in the Journal of Experimental Child Psychiatry, saw researchers test verbal working memories of 137 children between the ages of six and seven by asking them a series of trivia questions written on a card and told them that the answers to the questions were on the back.
The consumption of trans fats, most commonly used in processed foods to improve taste, texture and durability, may work to weaken the memory of young men, according to a new study. The study, published online in the journal PLOS ONE, evaluated data from 1,018 men and women, ages 20 to 85, who were asked to complete a dietary survey and memory test involving word recall.
More